Cara Therapeutic Stock Forecast - Accumulation Distribution
| CARA Stock | USD 0.31 0.01 3.33% |
Cara Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cara Therapeutic stock prices and determine the direction of Cara Therapeutic's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cara Therapeutic's historical fundamentals, such as revenue growth or operating cash flow patterns.
Cara |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 63561.87 | 0.12 |
| Check Cara Therapeutic Volatility | Backtest Cara Therapeutic | Information Ratio |
Cara Therapeutic Trading Date Momentum
| On November 23 2024 Cara Therapeutic was traded for 0.31 at the closing time. The top price for the day was 0.32 and the lowest listed price was 0.28 . There was no trading activity during the period 0.0. Lack of trading volume on November 23, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cara Therapeutic to competition |
Other Forecasting Options for Cara Therapeutic
For every potential investor in Cara, whether a beginner or expert, Cara Therapeutic's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cara. Basic forecasting techniques help filter out the noise by identifying Cara Therapeutic's price trends.Cara Therapeutic Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cara Therapeutic stock to make a market-neutral strategy. Peer analysis of Cara Therapeutic could also be used in its relative valuation, which is a method of valuing Cara Therapeutic by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cara Therapeutic Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cara Therapeutic's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cara Therapeutic's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cara Therapeutic Market Strength Events
Market strength indicators help investors to evaluate how Cara Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cara Therapeutic shares will generate the highest return on investment. By undertsting and applying Cara Therapeutic stock market strength indicators, traders can identify Cara Therapeutic entry and exit signals to maximize returns.
Cara Therapeutic Risk Indicators
The analysis of Cara Therapeutic's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cara Therapeutic's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.2 | |||
| Standard Deviation | 4.45 | |||
| Variance | 19.83 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cara Therapeutic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cara Therapeutic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cara Therapeutic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cara Therapeutic Stock:Check out Historical Fundamental Analysis of Cara Therapeutic to cross-verify your projections. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.86) | Return On Assets (0.63) | Return On Equity (1.84) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.